IP Library Assignment 056359/0869
Patent Assignment
Reel/Frame 056359/0869

Assignment of Assignor's Interest

Recorded: 2021-05-26 Pages: 3
Assignor
LAUMAS, SANDEEP
Executed: 2020-04-15
Assignee
INNOVATE BIOPHARMACEUTICALS, INC.
8480 HONEYCUTT ROAD, SUITE 200, RALEIGH, NORTH CAROLINA, 27615
Covered Properties (3)
Compositions and Methods for Potentiating Immune Checkpoint Inhibitor Therapy
Application: 16/982,115 →
Publication: US 2021/0361734
Larazotide Compositions and Methods for Treating Cancer
Application: 17/172,387 →
Publication: US 2021/0169968
Treatment of Cancer with Larazotide Derivatives in Combination with Immune Checkpoint Inhibitors
Application: 17/239,056 →
Publication: US 2021/0236586
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 26, 2021
From: MADAN, JAY
To: 9 METERS BIOPHARMA, INC.
Reel/Frame 056359/0858 →
Change of Name May 26, 2021
From: INNOVATE BIOPHARMACEUTICALS, INC.
To: 9 METERS BIOPHARMA, INC.
Reel/Frame 056396/0451 →
Intellectual Property Security Agreement Apr 10, 2023
From: 9 METERS BIOPHARMA, INC.; NAIA RARE DISEASES, LLC
To: HIGH TRAIL SPECIAL SITUATIONS LLC
Reel/Frame 063281/0653 →
Change of Name May 21, 2024
From: EBRIS PHARMA CO.
To: INTERLUDE BIOPHARMA CO.
Reel/Frame 067483/0848 →
Asset Purchase Agreement May 21, 2024
From: 9 METERS BIOPHARMA, INC.
To: EBRIS PHARMA CO.
Reel/Frame 068481/0001 →
Assignment of Assignor's Interest May 21, 2024
From: 9 METERS BIOPHARMA, INC.
To: EBRIS PHARMA CO.
Reel/Frame 067486/0001 →
Change of Name May 21, 2024
From: EBRIS PHARMA CO.
To: INTERLUDE BIOPHARMA CO.
Reel/Frame 067486/0809 →